Skip to main content
Log in

Time-Dependent Oral Absorption Models

  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

The plasma concentration–time profiles following oral administration of drugs are often irregular and cannot be interpreted easily with conventional models based on first- or zero-order absorption kinetics and lag time. Six new models were developed using a time-dependent absorption rate coefficient, ka(t), wherein the time dependency was varied to account for the dynamic processes such as changes in fluid absorption or secretion, in absorption surface area, and in motility with time, in the gastrointestinal tract. In the present study, the plasma concentration profiles of propranolol obtained in human subjects following oral dosing were analyzed using the newly derived models based on mass balance and compared with the conventional models. Nonlinear regression analysis indicated that the conventional compartment model including lag time (CLAG model) could not predict the rapid initial increase in plasma concentration after dosing and the predicted Cmax values were much lower than that observed. On the other hand, all models with the time-dependent absorption rate coefficient, ka(t), were superior to the CLAG model in predicting plasma concentration profiles. Based on Akaike's Information Criterion (AIC), the fluid absorption model without lag time (FA model) exhibited the best overall fit to the data. The two-phase model including lag time, TPLAG model was also found to be a good model judging from the values of sum of squares. This model also described the irregular profiles of plasma concentration with time and frequently predicted Cmax values satisfactorily. A comparison of the absorption rate profiles also suggested that the TPLAG model is better at prediction of irregular absorption kinetics than the FA model. In conclusion, the incorporation of a time-dependent absorption rate coefficient ka(t) allows the prediction of nonlinear absorption characteristics in a more reliable manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. V. S. Patel and W. G. Kramer. Allopurinol absorption from different sites of the rat gastrointestinal tract. J. Pharm. Sci. 75:275–277 (1986).

    Google Scholar 

  2. J. J. Tukker and F. G. J. Poelma. Site-dependent absorption in the rat intestine. Abstract, Third Int. Conf. on Drug Absorption, Edinburgh, p. 45, 1988.

  3. G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: The correlation of in v itro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420 (1995).

    Google Scholar 

  4. J. A. Clements, R. C. Heading, W. S. Nimmo, and L. F. Prescott. Kinetics of acetamin-ophen absorption and gastric emptying in man. Clin. Pharmacol. Ther. 24:420–431 (1978).

    Google Scholar 

  5. P. Langguth, K. M. Lee, H. Spahn-Langguth, and G. L. Amidon. Variable gastric empty-ing and discontinuities in drug absorption profiles: Dependence of rates and extent of cimetidine absorption on motility phase and pH. Biopharm. Drug Dispos. 15:719–746 (1994).

    Google Scholar 

  6. S. Haruta, N. Iwasaki, K. Ogawara, K. Higaki, and T. Kimura. Absorption behavior of orally administered drugs in rats treated with propantheline. J. Pharm. Sci. 87:1081–1085 (1998).

    Google Scholar 

  7. R. Sü verkrü p. Discontinuous absorption processes in pharmacokinetic models. J. Pharm. Sci. 68:1395–1400 (1979).

    Google Scholar 

  8. J. J. Zimmerman. Use of Metzler's NONLIN program for fitting discontinuous absorption profiles. J. Pharm. Sci. 72:138–142 (1983).

    Google Scholar 

  9. K. Murata, K. Noda, K. Kohno, and M. Samejima. Pharmacokinetic analysis of concen-tration data of drugs with irregular absorption profiles using multi-function absorption models. J. Pharm. Sci. 76:109–113 (1987).

    Google Scholar 

  10. R. L. Oberle and G. L. Amidon. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine: An explanation for the double peak phenomenon. J. Pharmacokin. Biopharm. 15:529–544 (1987).

    Google Scholar 

  11. T. Sawamoto, S. Haruta, Y. Kurosaki, K. Higaki, and T. Kimura. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J. Pharm. Pharmacol. 49:450–457 (1997).

    Google Scholar 

  12. B. E. Bleske, L. S. Welage, S. Rose, G. L. Amidon, and M. J. Shea. The effect of dosage release formulations on the pharmacokinetics of propranolol stereoisomers in humans. J. Clin. Pharmacol. 35:374–378 (1995).

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higaki, K., Yamashita, S. & Amidon, G.L. Time-Dependent Oral Absorption Models. J Pharmacokinet Pharmacodyn 28, 109–128 (2001). https://doi.org/10.1023/A:1011573831444

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011573831444

Navigation